Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The goal of the present study is to compare the effectiveness of the active (S)-enantiomer of citalopram, escitalopram with placebo in the treatment of patients with depressive syndrome complicating Alzheimer\'s dementia (AD), vascular dementia (VD) or mixed dementia (MD), for 8 weeks of double-blind treatment.
Epistemonikos ID: 00203e1b3afb6e2372e09a7512ee0a6db69da8f9
First added on: May 04, 2024